A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

Glycoconjugate Journal

Volumn 26, Issue 5, 2009, Pages 577-587

  Cochran, Siska ^a   Li, Cai Ping ^a   Ferro, Vito ^a,b  

^a Progen Pharmaceuticals Limited   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Heparan sulfate binding proteins; Heparin; Solution affinity assay; Surface plasmon resonance

Indexed keywords

BIOTIN; HEPARAN SULFATE BINDING PROTEIN; HEPARIN; HEPARIN BINDING PROTEIN; STREPTAVIDIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 2; VASCULOTROPIN A;

ARTICLE; MOLECULAR SENSOR; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE; HUMAN; METABOLISM; METHODOLOGY; PROTEIN BINDING;

CARRIER PROTEINS; CHEMOKINE CCL8; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEPARITIN SULFATE; HUMANS; INTERLEUKIN-8; PROTEIN BINDING; SURFACE PLASMON RESONANCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68949085385     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-008-9210-0     Document Type: Article

References (59)

1. B. Casu U. Lindahl 2001 Structure and biological interactions of heparin and heparan sulfate Adv. Carbohydr. Chem. Biochem. 57 159 206 11836942 10.1016/S0065-2318(01)57017-1 1:CAS:528:DC%2BD38XitVSjsL4%3D (Pubitemid 34121000)
2. J.M. Whitelock R.V. Iozzo 2005 Heparan sulfate: a complex polymer charged with biological activity Chem. Rev. 105 2745 2764 16011323 10.1021/cr010213m 1:CAS:528:DC%2BD2MXlsFKrtr4%3D (Pubitemid 41055329)
3. A. Ori M.C. Wilkinson D.G. Fernig 2008 The heparanome and regulation of cell function: structures, functions and challenges Front. Biosci. 13 4309 4338 18508513 10.2741/3007 1:CAS:528:DC%2BD1cXnsVOjsrg%3D (Pubitemid 351599686)
4. J.D. Esko U. Lindahl 2001 Molecular diversity of heparan sulfate J. Clin. Invest. 108 169 173 11457867 1:CAS:528:DC%2BD3MXlt1Klsb4%3D
5. J.R. Bishop M. Schuksz J.D. Esko 2007 Heparan sulphate proteoglycans fine-tune mammalian physiology Nature 446 1030 1037 17460664 10.1038/nature05817 1:CAS:528:DC%2BD2sXksFersrw%3D (Pubitemid 46676065)
6. R. Sasisekharan Z. Shriver G. Venkataraman U. Narayanasami 2002 Roles of heparan-sulphate glycosaminoglycans in cancer Nat. Rev. Cancer 2 521 528 12094238 10.1038/nrc842 1:CAS:528:DC%2BD38XkvFKltLY%3D
7. C.R. Parish 2006 The role of heparan sulphate in inflammation Nat. Rev. Immunol. 6 633 643 16917509 10.1038/nri1918 1:CAS:528:DC%2BD28Xos12gt78%3D (Pubitemid 44298213)
8. J. Liu S.C. Thorp 2002 Cell surface heparan sulfate and its roles in assisting viral infections Med. Res. Rev. 22 1 25 11746174 10.1002/med.1026 (Pubitemid 34019901)
9. I. Capila R.J. Linhardt 2002 Heparin-protein interactions Angew. Chem. Int. Ed. 41 391 412 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0. CO;2-B (Pubitemid 34149706)
10. D.R. Coombe W.C. Kett 2005 Heparan sulfate-protein interactions: therapeutic potential through structure-function insights Cell. Mol. Life Sci. 62 410 424 15719168 10.1007/s00018-004-4293-7 1:CAS:528:DC%2BD2MXksVagsLo%3D (Pubitemid 40385034)
11. R. Raman V. Sasisekharan R. Sasisekharan 2005 Structural insights into biological roles of protein-glycosaminoglycan interactions Chem. Biol. 12 267 277 15797210 10.1016/j.chembiol.2004.11.020 1:CAS:528:DC%2BD2MXis1Knu78%3D (Pubitemid 40406273)
12. V. Ferro K. Dredge L. Liu E. Hammond I. Bytheway C. Li K. Johnstone T. Karoli K. Davis E. Copeman A. Gautam 2007 PI-88 and novel heparan sulfate mimetics inhibit angiogenesis Semin. Thromb. Hemost. 33 557 568 17629854 10.1055/s-2007-982088 1:CAS:528:DC%2BD2sXptlKnsb0%3D
13. M. Presta D. Leali H. Stabile R. Ronca M. Camozzi L. Coco E. Moroni S. Liekens M. Rusnati 2003 Heparin derivatives as angiogenesis inhibitors Curr. Pharm. Des. 9 553 566 12570803 10.2174/1381612033391379 1:CAS:528: DC%2BD3sXhsVOhs70%3D (Pubitemid 36221723)
14. F.Y. Avci N.A. Karst R.J. Linhardt 2003 Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties Curr. Pharm. Des. 9 2323 2335 14529394 10.2174/1381612033453929 1:CAS:528:DC%2BD3sXotlWjt7k%3D (Pubitemid 37242946)
15. I. Capila V.A. VanderNoot T.R. Mealy B.A. Seaton R.J. Linhardt 1999 Interaction of heparin with annexin V FEBS Lett 446 327 330 10100868 10.1016/S0014-5793(99)00245-8 1:CAS:528:DyaK1MXhvVCmuro%3D (Pubitemid 29132753)
16. J. Dong C.A. Peters-Libeu K.H. Weisgraber B.W. Segelke B. Rupp I. Capila M.J. Hernaiz L.A. LeBrun R.J. Linhardt 2001 Interaction of the N-terminal domain of apolipoprotein E4 with heparin Biochemistry 40 2826 2834 11258893 10.1021/bi002417n 1:CAS:528:DC%2BD3MXnt1Kltw%3D%3D (Pubitemid 32198284)
17. O.A. Ibrahimi F. Zhang S.C. Hrstka M. Mohammadi R.J. Linhardt 2004 Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly Biochemistry 43 4724 4730 15096041 10.1021/bi0352320 1:CAS:528:DC%2BD2cXisFyis7w%3D (Pubitemid 38509093)
18. H. Mach D.B. Volkin C.J. Burke C.R. Middaugh R.J. Linhardt J.R. Fromm D. Loganathan L. Mattsson 1993 Nature of the interaction of heparin with acidic fibroblast growth factor Biochemistry 32 5480 5489 7684608 10.1021/bi00071a026 1:CAS:528:DyaK3sXisVyntLg%3D
19. R.M. Marks H. Lu R. Sundaresan T. Toida A. Suzuki T. Imanari M.J. Hernaiz R.J. Linhardt 2001 Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors J. Med. Chem. 44 2178 2187 11405655 10.1021/jm000412i 1:CAS:528:DC%2BD3MXjt1Oisrk%3D (Pubitemid 32861777)
20. S. Ricard-Blum O. Feraud H. Lortat-Jacob A. Rencurosi N. Fukai F. Dkhissi D. Vittet A. Imberty B.R. Olsen M. van der Rest 2004 Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling: role of divalent cations J. Biol. Chem. 279 2927 2936 14585835 10.1074/jbc.M309868200 1:CAS:528:DC%2BD2cXkslyhsQ%3D%3D (Pubitemid 38114285)
21. R.I. Osmond W.C. Kett S.E. Skett D.R. Coombe 2002 Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization Anal. Biochem. 310 199 207 12423639 10.1016/S0003-2697(02)00396-2 1:CAS:528:DC%2BD38XotlKisLg%3D (Pubitemid 35388262)
22. F. Zhang M. Fath R. Marks R.J. Linhardt 2002 A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies Anal. Biochem. 304 271 273 12009707 10.1006/abio.2002.5617 1:CAS:528: DC%2BD38XjsFOgs78%3D (Pubitemid 34522974)
23. S. Cochran C. Li J.K. Fairweather W.C. Kett D.R. Coombe V. Ferro 2003 Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonance J. Med. Chem. 46 4601 4608 14521421 10.1021/jm030180y 1:CAS:528:DC%2BD3sXnt1Ogtrc%3D (Pubitemid 37238760)
24. I. Bytheway S. Cochran 2004 Validation of molecular docking calculations involving FGF-1 and FGF-2 J. Med. Chem. 47 1683 1693 15027859 10.1021/jm030447t 1:CAS:528:DC%2BD2cXht12gtrg%3D (Pubitemid 38386630)
25. S. Cochran C.P. Li I. Bytheway 2005 An experimental and molecular-modeling study of the binding of linked sulfated tetracyclitols to FGF-1 and FGF-2 ChemBioChem 6 1882 1890 16175541 10.1002/cbic.200500089 1:CAS:528:DC%2BD2MXhtFentrnM (Pubitemid 41478767)
26. T. Karoli L. Liu J.K. Fairweather E. Hammond C.P. Li S. Cochran K. Bergefall E. Trybala R.S. Addison V. Ferro 2005 Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88) J. Med. Chem. 48 8229 8236 16366604 10.1021/jm050618p 1:CAS:528:DC%2BD2MXht1WltLzP (Pubitemid 43032531)
27. L. Liu I. Bytheway T. Karoli J.K. Fairweather S. Cochran C. Li V. Ferro 2008 Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides Bioorg. Med. Chem. Lett. 18 344 349 17981035 10.1016/j.bmcl.2007.10.071 1:CAS:528:DC%2BD1cXis1Wiuw%3D%3D
28. L. Liu C.P. Li S. Cochran V. Ferro 2004 Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries Bioorg. Med. Chem. Lett. 14 2221 2226 15081013 10.1016/j.bmcl.2004.02.017 1:CAS:528:DC%2BD2cXjtVehu7s%3D (Pubitemid 38488835)
29. A. Satoh H.E. Miwa K. Kojima J. Hirabayashi I. Matsumoto 2000 Ligand-binding properties of annexin from Caenorhabditis elegans (annexin XVI, Nex-1) J. Biochem. 128 377 381 10965035 1:CAS:528:DC%2BD3cXns1antb8%3D
30. K. Kamei X. Wu X. Xu K. Minami N.T. Huy R. Takano H. Kato S. Hara 2001 The analysis of heparin-protein interactions using evanescent wave biosensor with regioselectively desulfated heparins as the ligands Anal. Biochem. 295 203 213 11488623 10.1006/abio.2001.5193 1:CAS:528:DC%2BD3MXlslahtrg%3D (Pubitemid 32756975)
31. R. Karlsson 1994 Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors Anal. Biochem. 221 142 151 7985785 10.1006/abio.1994.1390 1:CAS:528:DyaK2cXlsFamtLw%3D (Pubitemid 24262784)
32. R. Karlsson H. Roos L. Fägerstam B. Persson 1994 Kinetic and concentration analysis using BIA technology Methods: A Companion to Methods Enzymol 6 99 110 10.1006/meth.1994.1013 1:CAS:528:DyaK2cXmt1Gls74%3D
33. W.C. Kett R.I. Osmond L. Moe S.E. Skett B.F. Kinnear D.R. Coombe 2003 Avidin is a heparin-binding protein. Affinity, specificity and structural analysis Biochim. Biophys. Acta 1620 225 234 12595093 1:CAS:528: DC%2BD3sXht1KlsL8%3D
34. E. Gemma O. Meyer D. Uhrín A.N. Hulme 2008 Enabling methodology for the end functionalisation of glycosaminoglycan oligosaccharides Mol. BioSystems 4 481 495 10.1039/b801666f 1:CAS:528:DC%2BD1cXmtVamurs%3D (Pubitemid 351706287)
35. A. Satoh I. Matsumoto 1999 Analysis of interaction between lectin and carbohydrate by surface plasmon resonance Anal. Biochem. 275 268 270 10552918 10.1006/abio.1999.4334 1:CAS:528:DyaK1MXntFWqsrc%3D
36. R.M. Lozano M. Jimenez J. Santoro M. Rico G. Gimenez-Gallego 1998 Solution structure of acidic fibroblast growth factor bound to 1,3, 6- naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistas J. Mol. Biol. 281 899 915 9719643 10.1006/jmbi.1998.1977 1:CAS:528:DyaK1cXmtVygs74%3D (Pubitemid 28408437)
37. D.B. Volkin A.M. Verticelli K.E. Marfia C.J. Burke H. Mach C.R. Middaugh 1993 Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor Biochim. Biophys. Acta 1203 18 26 7692970 1:CAS:528:DyaK2cXitlehsg%3D%3D
38. L. Nieba A. Krebber A. Pluckthun 1996 Competition BIAcore for measuring true affinities: large differences from values determined from binding kinetics Anal. Biochem. 234 155 165 8714593 10.1006/abio.1996.0067 1:CAS:528: DyaK28XhtFarsrY%3D (Pubitemid 26063796)
39. S.J. Goodger C.J. Robinson K.J. Murphy N. Gasiunas N.J. Harmer T.L. Blundell D.A. Pye J.T. Gallagher 2008 Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms J. Biol. Chem. 283 13001 13008 18281281 10.1074/jbc.M704531200 1:CAS:528:DC%2BD1cXltlGrt7k%3D
40. C.J. Robinson N.J. Harmer S.J. Goodger T.L. Blundell J.T. Gallagher 2005 Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes J. Biol. Chem. 280 42274 42282 16219767 10.1074/jbc.M505720200 1:CAS:528:DC%2BD2MXhtlajs77E (Pubitemid 43023198)
41. T. Spivak-Kroizman M.A. Lemmon I. Dikic J.E. Ladbury D. Pinchasi J. Huang M. Jaye G. Crumley J. Schlessinger I. Lax 1994 Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Cell 79 1015 1024 7528103 10.1016/0092-8674(94)90032-9 1:CAS:528:DyaK2MXislCgsbo%3D
42. L.Y. Li A.P. Seddon 1994 Fluorospectrometric analysis of heparin interaction with fibroblast growth factors Growth Factors 11 1 7 7530465 10.3109/08977199409015046
43. H. Mach C.R. Middaugh 1994 Probing the affinity of polyanions for acidic fibroblast growth factor by unfolding kinetics Arch. Biochem. Biophys. 309 36 42 7509590 10.1006/abbi.1994.1080 1:CAS:528:DyaK2cXitlymsr0%3D (Pubitemid 24171438)
44. D.J. Francis C.R. Parish M. McGarry F.S. Santiago H.C. Lowe K.J. Brown J.A. Bingley I.P. Hayward W.B. Cowden J.H. Campbell G.R. Campbell C.N. Chesterman L.M. Khachigian 2003 Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation Circ. Res. 92 e70 77 12690039 10.1161/01.RES.0000071345.76095.07 1:CAS:528:DC%2BD3sXjtFajsr4%3D
45. M.K. Lee A.D. Lander 1991 Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach Proc. Natl. Acad. Sci. U. S. A. 88 2768 2772 1901416 10.1073/pnas.88.7.2768 1:CAS:528:DyaK3MXitVaqsLw%3D
46. S. Ashikari-Hada H. Habuchi Y. Kariya N. Itoh A.H. Reddi K. Kimata 2004 Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library J. Biol. Chem. 279 12346 12354 14707131 10.1074/jbc.M313523200 1:CAS:528:DC%2BD2cXitl2gs78%3D (Pubitemid 38445801)
47. D. Krilleke A. DeErkenez W. Schubert I. Giri G.S. Robinson Y.S. Ng D.T. Shima 2007 Molecular mapping and functional characterization of the VEGF164 heparin-binding domain J. Biol. Chem. 282 28045 28056 17626017 10.1074/jbc.M700319200 1:CAS:528:DC%2BD2sXhtVeisr3K (Pubitemid 47533565)
48. E. Krieger E. Geretti B. Brandner B. Goger T.N. Wells A.J. Kungl 2004 A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations Proteins 54 768 775 14997572 10.1002/prot.10590 1:CAS:528:DC%2BD2cXitVGguro%3D (Pubitemid 38298795)
49. A.Z. Dudek C.A. Pennell T.D. Decker T.A. Young N.S. Key A. Slungaard 1997 Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C J. Biol. Chem. 272 31785 31792 9395524 10.1074/jbc.272.50.31785 1:CAS:528: DyaK2sXotVSku7g%3D (Pubitemid 28013329)
50. K.H. Mayo V. Roongta E. Ilyina R. Milius S. Barker C. Quinlan G. La Rosa T.J. Daly 1995 NMR solution structure of the 32-kDa platelet factor 4 ELR-motif N-terminal chimera: a symmetric tetramer Biochemistry 34 11399 11409 7547867 10.1021/bi00036a012 1:CAS:528:DyaK2MXnslKgurk%3D
51. S.O. Kolset D.M. Mann L. Uhlin-Hansen J.O. Winberg E. Ruoslahti 1996 Serglycin-binding proteins in activated macrophages and platelets J. Leukoc. Biol. 59 545 554 8613703 1:CAS:528:DyaK28XisFSrt7o%3D
52. J. Watton C. Longstaff D.A. Lane T.W. Barrowcliffe 1993 Heparin binding affinity of normal and genetically modified antithrombin III measured using a monoclonal antibody to the heparin binding site of antithrombin III Biochemistry 32 7286 7293 8343518 10.1021/bi00079a027 1:CAS:528:DyaK3sXksVKjuro%3D
53. Conrad, H.E.: Antithrombin, the prototypic heparin-binding protein. In Heparin-Binding Proteins, pp. 203-238. Academic, San Diego (1998)
54. L.D. Thompson M.W. Pantoliano B.A. Springer 1994 Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain Biochemistry 33 3831 3840 8142385 10.1021/bi00179a006 1:CAS:528:DyaK2cXitVyksb0%3D
55. B. Goger Y. Halden A. Rek R. Mosl D. Pye J. Gallagher A.J. Kungl 2002 Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites Biochemistry 41 1640 1646 11814358 10.1021/bi011944j 1:CAS:528: DC%2BD38Xis1yjtQ%3D%3D (Pubitemid 34112754)
56. D.P. Witt A.D. Lander 1994 Differential binding of chemokines to glycosaminoglycan subpopulations Curr. Biol. 4 394 400 7922353 10.1016/S0960-9822(00)00088-9 1:CAS:528:DyaK2cXktlart74%3D (Pubitemid 2085143)
57. K.E. Forsten N. Wang R.M. Robinson M.A. Nugent 2000 A simple assay for evaluating inhibitors of proteoglycan-ligand binding Ann. Biomed. Eng. 28 119 127 10645795 10.1114/1.260 1:STN:280:DC%2BD3c7gvVeqsQ%3D%3D (Pubitemid 30563022)
58. T. Arakawa J. Wen J.S. Philo 1993 Densimetric determination of equilibrium binding of sucrose octasulfate with basic fibroblast growth factor J. Protein Chem. 12 689 693 8136019 10.1007/BF01024927 1:CAS:528: DyaK2cXmvFyrtg%3D%3D (Pubitemid 24014954)
59. J. Blaszczyk E.V. Coillie P. Proost J.V. Damme G. Opdenakker G.D. Bujacz J.M. Wang X. Ji 2000 Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors Biochemistry 39 14075 14081 11087354 10.1021/bi0009340 1:CAS:528:DC%2BD3cXnsVKgu7o%3D (Pubitemid 30842316)